NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

OM

Outset Medical Inc

Apr 04 • 12:08PM ET

9.90

Dollar change -1.17
Percentage change -10.57	%

Healthcare • Medical Devices • USA • NASD

Peers: FMS BAX PODD INSP RMD AXNX NARI NVRO OFIX MDXG

| Held by: VTI VXF VHT IWC PRFZ BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-37.32	Insider Own	2.53%	Shs Outstand	3.53M	Perf Week	-21.30%
Market Cap	175.22M	Forward P/E	-	EPS next Y	-7.90	Insider Trans	-41.36%	Shs Float	3.50M	Perf Month	4.75%
Income	-127.98M	PEG	-	EPS next Q	-3.00	Inst Own	94.54%	Short Float	22.51%	Perf Quarter	-43.59%
Sales	113.69M	P/S	1.54	EPS this Y	65.72%	Inst Trans	-	Short Ratio	8.07	Perf Half Y	6.90%
Book/sh	7.60	P/B	1.30	EPS next Y	14.20%	ROA	-43.41%	Short Interest	0.79M	Perf Year	-67.49%
Cash/sh	8.97	P/C	1.10	EPS next 5Y	55.16%	ROE	-170.97%	52W Range	5.85 - 78.30	Perf YTD	-40.54%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-4.06%	ROI	-56.41%	52W High	-87.36%	Beta	1.86
Dividend TTM	-	Quick Ratio	4.38	Sales past 5Y	69.86%	Gross Margin	33.96%	52W Low	69.23%	ATR (14)	1.42
Dividend Ex-Date	-	Current Ratio	5.69	EPS Y/Y TTM	28.80%	Oper. Margin	-98.49%	RSI (14)	45.54	Volatility	12.22% 14.87%
Employees	-	Debt/Eq	7.53	Sales Y/Y TTM	-12.80%	Profit Margin	-112.57%	Recom	1.80	Target Price	30.00
Option/Short	Yes / No	LT Debt/Eq	7.46	EPS Q/Q	36.71%	Payout	-	Rel Volume	1.04	Prev Close	11.07
Sales Surprise	3.59%	EPS Surprise	16.04%	Sales Q/Q	-3.41%	Earnings	Feb 19 AMC	Avg Volume	97.61K	Price	9.90
SMA20	-2.08%	SMA50	-11.64%	SMA200	-49.83%	Trades		Volume	44,065	Change	-10.57%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-08-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$6 → $3
Jun-21-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$5 → $6
Apr-08-24	Initiated	BTIG Research	Buy	$6
Apr-05-24	Upgrade	CL King	Neutral → Buy	$6
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$14 → $6
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform	$32 → $3
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform	$23
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$48 → $20
Mar-02-22	Resumed	BofA Securities	Buy	$50
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$50
Aug-18-21	Initiated	Cowen	Outperform	$70
Apr-19-21	Initiated	Wells Fargo	Overweight	$63
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	SVB Leerink	Mkt Perform	$60
Oct-12-20	Initiated	Stifel	Buy	$54
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight	$48
Oct-12-20	Initiated	Goldman	Buy	$54
Oct-12-20	Initiated	BofA Securities	Buy	$54
Oct-12-20	Initiated	Barclays	Overweight

Show Previous Ratings

Apr-02-25 09:55AM	Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know (Zacks) +11.37%
Mar-21-25 06:35AM	Why Outset Medical Inc. (OM) Surged On Thursday? (InsiderMonkey) -10.90%
Mar-18-25 08:30AM	Outset Medical Announces One-for-Fifteen Reverse Stock Split (GlobeNewswire)
Feb-26-25 09:55AM	Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now (Zacks) -6.51%
Feb-24-25 04:03PM	Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference (GlobeNewswire) -6.82%
02:14PM	Loading…
Feb-20-25 02:14PM	Q4 2024 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
02:13AM	Outset Medical Inc (OM) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
Feb-19-25 05:15PM	Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:03PM	Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00AM	Earnings To Watch: Outset Medical Inc (OM) Reports Q4 2024 Result (GuruFocus.com)
Feb-13-25 04:35PM	Outset Medical Announces Resolution of Warning Letter (GlobeNewswire) +5.12% +9.65%
Feb-12-25 10:00AM	Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Feb-03-25 09:00AM	Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025 (GlobeNewswire)
Jan-08-25 09:00AM	Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -11.22%
Jan-07-25 05:29AM	Outset Medical to pay down debt after raising nearly $300M (MedTech Dive) -13.39%
08:30AM	Loading…
Jan-06-25 08:30AM	Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors (GlobeNewswire) -9.29%
Nov-15-24 09:00AM	Outset Medical to Present at the 2024 Stifel Healthcare Conference (GlobeNewswire) -8.01%
Nov-11-24 10:05AM	Outset Medical (OM) Slipped on Earnings Miss and Reduced Guidance (Insider Monkey) +11.24%
Nov-07-24 04:00PM	Outset Medical Inc (OM) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com) +25.18%
Nov-06-24 05:25PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Outset Medical Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-05-24 08:09AM	Outset Medical Inc (OM) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-23-24 04:05PM	New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo (GlobeNewswire) -6.06%
09:00AM	Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024 (GlobeNewswire)
Oct-18-24 04:25AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (Newsfile)
Oct-16-24 06:56PM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) -7.94%
Oct-14-24 01:27PM	Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights OM (GlobeNewswire)
Oct-11-24 06:45AM	Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire)
Sep-27-24 08:26AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) +16.12%
Sep-23-24 03:57PM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) -10.12%
09:13AM	Loading…
Sep-20-24 09:13AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire)
Sep-17-24 05:45AM	Outset Medical, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire)
Sep-13-24 05:45AM	Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire) +17.67%
Sep-12-24 01:23AM	Analysis of AMERIPRISE FINANCIAL INC's Recent Trade in Outset Medical Inc (GuruFocus.com) -11.69%
01:14AM	Morgan Stanley's Strategic Reduction in Outset Medical Inc Shares (GuruFocus.com)
01:08AM	JPMorgan Chase & Co's Strategic Reduction in Outset Medical Inc (GuruFocus.com)
Sep-11-24 03:44PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (Newsfile)
Sep-09-24 04:10PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Sep-06-24 01:47PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Sep-04-24 03:23PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (Newsfile)
Sep-03-24 11:57AM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Aug-31-24 05:52PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, BrightSpring, Outset, and NuScale and Encourages Investors to Contact the Firm (GlobeNewswire) -5.28%
Aug-07-24 06:35PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -68.53%
04:03PM	Outset Medical Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-31-24 10:01AM	Will Outset Medical, Inc. (OM) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-24-24 09:00AM	Outset Medical to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 (Business Wire) -5.65%
Jul-01-24 06:00AM	3 MedTech Stocks to Buy for Healthy Gains (InvestorPlace)
Jun-10-24 12:00PM	Outset Medical (OM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) -8.44%
Jun-03-24 04:05PM	Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
May-13-24 06:59AM	Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating (MT Newswires)
May-10-24 03:48PM	Outset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens Losses (GuruFocus.com) -6.12%
May-09-24 03:44PM	Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript (Insider Monkey) -20.82%
09:42AM	Q1 2024 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
03:57AM	Outset Medical Inc (OM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
May-08-24 08:58PM	OM Stock Earnings: Outset Medical Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +8.97%
05:45PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:02PM	Outset Medical Reports First Quarter 2024 Financial Results (Business Wire)
May-06-24 08:48AM	Outset Medical Receives US FDA 510(k) Clearance for TabloCart With Prefiltration -- Shares Surge 13% Pre-Bell (MT Newswires) +20.70%
08:00AM	Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance (Business Wire)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 04:30PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire) +12.65% +5.26%
Apr-19-24 08:30AM	Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (Business Wire)
Apr-18-24 01:36PM	Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis (Zacks)
Apr-17-24 08:30AM	Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S. (Business Wire)
Apr-15-24 08:30AM	Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care (Business Wire)
Mar-13-24 04:02PM	Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors (Business Wire) -10.70%
Mar-05-24 03:34PM	Why Dialysis Stocks Are up Today (The Wall Street Journal)
Feb-26-24 09:00AM	Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference (Business Wire)
Feb-22-24 10:51AM	Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript (Insider Monkey) +6.23%
07:10AM	Q4 2023 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:49PM	Outset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-20-24 04:25PM	ROLLINS, INC. ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS (PR Newswire)
Feb-05-24 10:00AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) +5.76%
08:30AM	Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024 (Business Wire)
Jan-08-24 08:30AM	Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance (Business Wire)
Jan-03-24 08:30AM	Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-29-23 04:05PM	Outset Medical to Present at BofA Home Care Conference (Business Wire) +5.70%
Nov-25-23 11:43AM	5 Struggling Stocks to Buy at a Discount (Motley Fool)
Nov-23-23 06:30AM	2 of the Cheapest Stocks I Own (Motley Fool)
Nov-16-23 02:46PM	Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm's Attorneys (GlobeNewswire)
Nov-09-23 04:05PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Nov-07-23 04:31PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire) -14.39%
04:05PM	Outset Medical Reports Third Quarter 2023 Financial Results (Business Wire)
Nov-02-23 10:00AM	Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for (Zacks) +7.18%
09:35AM	After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM) (Zacks)
Nov-01-23 09:00AM	New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo Hemodialysis System on Equitable Kidney Care (Business Wire) +6.21%
Oct-31-23 02:00PM	Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm (GlobeNewswire) +15.31%
10:01AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-30-23 04:05PM	Outset Medical to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023 (Business Wire)
Oct-27-23 11:42AM	Hagens Berman Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
Oct-19-23 12:31PM	Outset Medical (PM) Investigated for Possible Securities Law Violations, Hagens Berman Encourages Investors with Losses to Contact its Attorneys (GlobeNewswire) -6.67%
Oct-17-23 05:36PM	Outset Medical, Inc.: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
09:35AM	Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM) (Zacks)
Oct-16-23 08:14AM	Outset Medical, Inc. (NASDAQ:OM) Q3 2023 Earnings Call Transcript (Insider Monkey) +15.04%
Oct-13-23 07:21PM	Outset Medical stock nosedives due to FDA warning letter headwinds Hagens Berman (GlobeNewswire) -49.93%
09:50AM	Netflix downgraded, Applied Materials upgraded: Wall Street's top analyst calls (The Fly)
Oct-12-23 04:05PM	Outset Medical Reports Preliminary Third Quarter 2023 Financial Results (Business Wire) -11.33%
Aug-29-23 04:05PM	Outset Medical to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trigg Leslie	Chair and CEO	Feb 18 '25	Sale	0.90	14,611	13,150	880,969	Feb 19 04:30 PM
Nash Marc	SVP Operations and R&D	Feb 18 '25	Sale	0.90	4,204	3,784	200,764	Feb 19 04:29 PM
Brottem John L.	General Counsel	Feb 18 '25	Sale	0.90	6,145	5,530	175,043	Feb 19 04:26 PM
Ahmed Nabeel	Chief Financial Officer	Feb 18 '25	Sale	0.90	8,659	7,793	250,210	Feb 19 04:23 PM
Trigg Leslie	Officer	Feb 18 '25	Proposed Sale	0.90	14,611	13,150		Feb 18 07:18 PM
Nash Marc	Officer	Feb 18 '25	Proposed Sale	0.90	4,204	3,784		Feb 18 06:54 PM
Brottem John L.	Officer	Feb 18 '25	Proposed Sale	0.90	6,145	5,530		Feb 18 06:52 PM
Ahmed Nabeel	Officer	Feb 18 '25	Proposed Sale	0.90	8,659	7,793		Feb 18 06:51 PM
Trigg Leslie	Chair and CEO	Jan 21 '25	Sale	0.80	65,236	52,189	895,580	Jan 22 06:05 PM
Nash Marc	SVP Operations and R&D	Jan 21 '25	Sale	0.80	23,221	18,577	204,968	Jan 22 06:04 PM
Brottem John L.	General Counsel	Jan 21 '25	Sale	0.80	32,930	26,344	181,188	Jan 22 06:03 PM
Ahmed Nabeel	Chief Financial Officer	Jan 21 '25	Sale	0.80	34,288	27,430	258,869	Jan 22 06:02 PM
Trigg Leslie	Officer	Jan 21 '25	Proposed Sale	0.80	65,236	52,189		Jan 21 06:13 PM
Nash Marc	Officer	Jan 21 '25	Proposed Sale	0.80	23,221	18,577		Jan 21 06:10 PM
Brottem John L.	Officer	Jan 21 '25	Proposed Sale	0.80	32,930	26,344		Jan 21 06:09 PM
Ahmed Nabeel	Officer	Jan 21 '25	Proposed Sale	0.80	34,288	27,430		Jan 21 06:06 PM
Trigg Leslie	Chair and CEO	Jan 13 '25	Sale	0.81	33,227	26,914	861,397	Jan 13 06:51 PM
Nash Marc	SVP Operations and R&D	Jan 13 '25	Sale	0.81	15,011	12,159	222,291	Jan 13 06:36 PM
Brottem John L.	General Counsel	Jan 13 '25	Sale	0.81	20,492	16,599	205,028	Jan 13 06:34 PM
Ahmed Nabeel	Chief Financial Officer	Jan 13 '25	Sale	0.81	29,031	23,515	279,901	Jan 13 06:32 PM
Trigg Leslie	Officer	Jan 13 '25	Proposed Sale	0.81	33,227	26,914		Jan 13 06:28 PM
Nash Marc	Officer	Jan 13 '25	Proposed Sale	0.81	15,011	12,159		Jan 13 06:20 PM
Brottem John L.	Officer	Jan 13 '25	Proposed Sale	0.81	20,492	16,599		Jan 13 05:59 PM
Ahmed Nabeel	Officer	Jan 13 '25	Proposed Sale	0.81	29,031	23,515		Jan 13 05:46 PM
Trigg Leslie	Chair and CEO	Jan 07 '25	Sale	1.29	10,227	13,193	894,624	Jan 07 07:32 PM
Nash Marc	SVP Operations and R&D	Jan 07 '25	Sale	1.29	720	929	237,302	Jan 07 07:28 PM
Brottem John L.	General Counsel	Jan 07 '25	Sale	1.29	1,572	2,028	225,520	Jan 07 07:26 PM
Ahmed Nabeel	Chief Financial Officer	Jan 07 '25	Sale	1.29	1,835	2,367	308,932	Jan 07 07:24 PM
Trigg Leslie	Officer	Jan 07 '25	Proposed Sale	1.29	10,227	13,193		Jan 07 07:04 PM
Nash Marc	Officer	Jan 07 '25	Proposed Sale	1.29	720	929		Jan 07 06:55 PM
Brottem John L.	Officer	Jan 07 '25	Proposed Sale	1.29	1,572	2,028		Jan 07 06:27 PM
Ahmed Nabeel	Officer	Jan 07 '25	Proposed Sale	1.29	1,835	2,367		Jan 07 06:07 PM
Trigg Leslie	Chair and CEO	Nov 15 '24	Sale	0.80	5,645	4,516	904,851	Nov 18 05:49 PM
Nash Marc	SVP Operations and R&D	Nov 15 '24	Sale	0.80	1,375	1,100	238,022	Nov 18 05:48 PM
Brottem John L.	General Counsel	Nov 15 '24	Sale	0.80	3,203	2,562	227,092	Nov 18 05:45 PM
Ahmed Nabeel	Chief Financial Officer	Nov 15 '24	Sale	0.80	4,221	3,377	310,767	Nov 18 05:44 PM
Trigg Leslie	Officer	Nov 15 '24	Proposed Sale	0.80	5,645	4,516		Nov 15 07:26 PM
Nash Marc	Officer	Nov 15 '24	Proposed Sale	0.80	1,375	1,100		Nov 15 07:25 PM
Brottem John L.	Officer	Nov 15 '24	Proposed Sale	0.80	3,203	2,562		Nov 15 07:23 PM
Ahmed Nabeel	Officer	Nov 15 '24	Proposed Sale	0.80	4,221	3,377		Nov 15 07:22 PM
Trigg Leslie	Chair and CEO	Aug 15 '24	Sale	0.84	5,308	4,459	910,496	Aug 15 08:02 PM
Nash Marc	SVP Operations and R&D	Aug 15 '24	Sale	0.84	1,293	1,086	239,397	Aug 15 08:01 PM
Brottem John L.	General Counsel	Aug 15 '24	Sale	0.84	3,011	2,529	230,295	Aug 15 07:59 PM
Ahmed Nabeel	Chief Financial Officer	Aug 15 '24	Sale	0.84	3,971	3,336	314,988	Aug 15 07:57 PM
Trigg Leslie	Officer	Aug 15 '24	Proposed Sale	0.84	5,308	4,459		Aug 15 06:49 PM
Nash Marc	Officer	Aug 15 '24	Proposed Sale	0.84	1,293	1,086		Aug 15 06:49 PM
Brottem John L.	Officer	Aug 15 '24	Proposed Sale	0.84	3,011	2,529		Aug 15 06:47 PM
Ahmed Nabeel	Officer	Aug 15 '24	Proposed Sale	0.84	3,971	3,336		Aug 15 06:46 PM
Nash Marc	SVP Operations and R&D	Jul 24 '24	Sale	4.02	723	2,906	240,690	Jul 24 07:08 PM
Brottem John L.	General Counsel	Jun 12 '24	Sale	4.78	10,569	50,520	233,306	Jun 14 04:17 PM
GROSSMAN D KEITH	Director	Jun 03 '24	Option Exercise	1.11	69,303	76,926	85,922	Jun 03 06:57 PM
GROSSMAN D KEITH	Director	Jun 03 '24	Sale	3.78	38,117	144,234	47,805	Jun 03 06:57 PM
Ahmed Nabeel	Chief Financial Officer	May 16 '24	Sale	3.53	3,918	13,831	318,959	May 17 05:40 PM
Nash Marc	SVP Operations and R&D	May 16 '24	Sale	3.53	1,097	3,872	241,413	May 17 05:38 PM
Brottem John L.	General Counsel	May 16 '24	Sale	3.53	2,972	10,491	243,875	May 17 05:36 PM
Trigg Leslie	Chair and CEO	May 16 '24	Sale	3.53	5,237	18,487	915,804	May 17 05:25 PM
Racine Jean-Olivier	Chief Technology Officer	May 10 '24	Sale	3.27	8,306	27,161	265,325	May 10 06:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OM

Outset Medical Inc

Upgrade your FINVIZ experience